Latest Breaking News On - Linical stage immunotherapy company - Page 1 : comparemela.com

PDS Biotechnology Corp. (PDSB), a clinical-stage immunotherapy company, Monday, reported a wider loss for the first quarter, particularly impacted by personnel, clinical studies, medical affairs, and manufacturing expenses.

Thomson reutersBiotechnology corpLoss widens in q1Pds biotechnology corpLinical stage immunotherapy company